Results 221 to 230 of about 8,503,937 (347)
Cardiovascular Risk Reduction and Achievement of the Year 2000 Health Objectives [PDF]
Matilda A. Babbitz
openalex +1 more source
Fiber‐reinforced elastin‐like tubular scaffolds are engineered to achieve anisotropic and reversible actuation under external stimuli. By adjusting fiber's angle, actuation behavior is finely tuned, enabling distinct actuation responses, even within different regions of the same scaffold.
Federica Sallustio+7 more
wiley +1 more source
Predicting cardiovascular risk with hybrid ensemble learning and explainable AI. [PDF]
Shah P, Shukla M, Dholakia NH, Gupta H.
europepmc +1 more source
Correlations between haemostasis parameters and several cardiovascular risk factors in man [PDF]
S. H. J. Donders
openalex +1 more source
Intrinsically Soft Implantable Electronics for Long‐term Biosensing Applications
Intrinsically soft implantable biosensors address the mechanical mismatch of conventional rigid implants, improving biocompatibility and stability. This review explores soft encapsulation matrices, stretchable conductors, implantation strategies, and chronic fixation techniques.
Su Hyeon Lee+5 more
wiley +1 more source
Comorbidity and cardiovascular risk factors in multiple sclerosis. [PDF]
Barzegar M+14 more
europepmc +1 more source
A deployable, chip‐integrated approach to the detection of heart attack biomarkers is demonstrated using silicon photonic microring resonators combined with microfluidics. By applying the Pound–Drever–Hall frequency locking technique, sensor signals are measured with improved signal‐to‐noise ratio, applying this to real‐time, selective readouts.
Evan Diamandikos+9 more
wiley +1 more source
MAFLD as a Cardiovascular Risk Factor: An Extended Retrospective Study with a Control Group. [PDF]
Szymala-Pędzik M+5 more
europepmc +1 more source
Computational fluid dynamics analyses assess the upstream locomotion performance of anisotropic microrollers with varying height‐to‐width ratios. Observing their successful upstream locomotion in veins, their performance in hepatic circulation is investigated for treating primary liver cancer.
Burak Arslan+8 more
wiley +1 more source